ISB Corporation
ISB Corporation Fundamental Analysis
ISB Corporation (9702.T) shows moderate financial fundamentals with a PE ratio of 16.12, profit margin of 3.88%, and ROE of 10.30%. The company generates $37.0B in annual revenue with moderate year-over-year growth of 4.84%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 48.0/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze 9702.T's fundamental strength across five key dimensions:
Efficiency Score
Weak9702.T struggles to generate sufficient returns from assets.
Valuation Score
Moderate9702.T shows balanced valuation metrics.
Growth Score
Moderate9702.T shows steady but slowing expansion.
Financial Health Score
Excellent9702.T maintains a strong and stable balance sheet.
Profitability Score
Weak9702.T struggles to sustain strong margins.
Key Financial Metrics
Is 9702.T Expensive or Cheap?
P/E Ratio
9702.T trades at 16.12 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, 9702.T's PEG of 35.91 indicates potential overvaluation.
Price to Book
The market values ISB Corporation at 1.59 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 11.54 times EBITDA. This signals the market has high growth expectations.
How Well Does 9702.T Make Money?
Net Profit Margin
For every $100 in sales, ISB Corporation keeps $3.88 as profit after all expenses.
Operating Margin
Core operations generate 6.25 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $10.30 in profit for every $100 of shareholder equity.
ROA
ISB Corporation generates $6.64 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
ISB Corporation generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
ISB Corporation generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
9702.T converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
16.12
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
35.91
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.59
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.62
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.008
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.77
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.10
vs 25 benchmark
ROA
Return on assets percentage
0.07
vs 25 benchmark
ROCE
Return on capital employed
0.15
vs 25 benchmark
How 9702.T Stacks Against Its Sector Peers
| Metric | 9702.T Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 16.12 | 34.43 | Better (Cheaper) |
| ROE | 10.30% | 1135.00% | Weak |
| Net Margin | 3.88% | -134663.00% (disorted) | Weak |
| Debt/Equity | 0.01 | 7.92 | Strong (Low Leverage) |
| Current Ratio | 2.77 | 5.77 | Strong Liquidity |
| ROA | 6.64% | -310462.00% (disorted) | Weak |
9702.T outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews ISB Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
34.67%
Industry Style: Growth, Innovation, High Beta
High GrowthEPS CAGR
186.65%
Industry Style: Growth, Innovation, High Beta
High GrowthFCF CAGR
24.68%
Industry Style: Growth, Innovation, High Beta
High Growth